Persistent Platelet-Monocyte CrossTalk Underlies Failure to Resolve Inflammation and Symptoms in ME/CFS
Fördersumme: € 35.860
ME/CFS Biobank Austria
Dauer: 18 Monate, Fördersumme: € 100.000
Designing synthetic antigen-presenting cells to determine the 3D nanoenvironment of T-cell antigen recognition
Dauer: 48 Monate, Fördersumme: € 897.677
Deciphering systemic and mucosal antibody repertoires against the microbiota in ME/CFS and PCC
Dauer: 15 Monate, Fördersumme: € 99.426
The impact of mast cell activation on epithelial and endothelial barrier dysregulation in post-infectious ME/CFS
Dauer: 12 Monate, Fördersumme: € 99.992
Exploring the Glycome: Identifying Glycosylation-Related Biomarkers for severity stratification in Chronic Fatigue Syndrome
Dauer: 12 Monate, Fördersumme: € 99.946